Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Yuli Lin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8779-2471; OpenAlex author ID A5021737826. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
21
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 5

  1. Nicotinamide riboside enhances the efficacy of gemcitabine and suppresses PDAC premalignant lesions via SIRT3 activation. Last author DOI 10.1016/j.bcp.2025.117585↗
  2. GPRC5A/CXCL8/NLRP3-mediated neutrophil extracellular traps drive gemcitabine-nab-paclitaxel resistance in pancreatic adenocarcinoma. Co-author DOI 10.20892/j.issn.2095-3941.2025.0040↗
  3. Pancreatic STAT5 activation promotes Kras G12D-induced and inflammation-induced acinar-to-ductal metaplasia and pancreatic cancer. Co-author DOI 10.1136/gutjnl-2024-332225↗
  4. Lactate-Modulated Immunosuppression of Myeloid-Derived Suppressor Cells Contributes to the Radioresistance of Pancreatic Cancer. Last author DOI 10.1158/2326-6066.cir-20-0111↗
  5. A Systematic Inflammation-based Model in Advanced Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.7150/jca.30561↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xuguang Yang · 3 shared papers, 2019–2026 · strength 0.49
  2. Zhihao Wu · 2 shared papers, 2024–2026 · strength 0.49
  3. Qing Xia · 1 shared paper, 2025 · strength 0.26
  4. Yukuan Feng · 1 shared paper, 2025 · strength 0.26
  5. Tianyi Zhu · 1 shared paper, 2025 · strength 0.26
  6. Junjie Hang · 2 shared papers, 2019–2020 · strength 0.19
  7. Xiangjun Meng · 1 shared paper, 2024 · strength 0.18
  8. Jun Wang · 1 shared paper, 2024 · strength 0.18
  9. Qing Xia · 1 shared paper, 2024 · strength 0.18
  10. Wenquan Wang · 1 shared paper, 2024 · strength 0.18
  11. Liang Liu · 1 shared paper, 2024 · strength 0.18
  12. Xuguang Yang · 1 shared paper, 2024 · strength 0.18
  13. Junfeng Zhang · 1 shared paper, 2020 · strength 0.10
  14. Tiening Zhang · 1 shared paper, 2020 · strength 0.10
  15. Liwei Wang · 1 shared paper, 2020 · strength 0.10
  16. Rong Hua · 1 shared paper, 2020 · strength 0.10
  17. Yan‐Miao Huo · 1 shared paper, 2020 · strength 0.10
  18. Hua Jiang · 1 shared paper, 2019 · strength 0.09
  19. Hanyu Zhou · 1 shared paper, 2019 · strength 0.09
  20. Kequn Xu · 1 shared paper, 2019 · strength 0.09
  21. Lixia Wu · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.